000 | 01872 a2200553 4500 | ||
---|---|---|---|
005 | 20250516181021.0 | ||
264 | 0 | _c20140416 | |
008 | 201404s 0 0 eng d | ||
022 | _a0006-3002 | ||
024 | 7 |
_a10.1016/j.bbadis.2013.11.001 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRemels, A H V | |
245 | 0 | 0 |
_aClassical NF-κB activation impairs skeletal muscle oxidative phenotype by reducing IKK-α expression. _h[electronic resource] |
260 |
_bBiochimica et biophysica acta _cFeb 2014 |
||
300 |
_a175-85 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aI-kappa B Kinase _xgenetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMuscle Fibers, Skeletal _xdrug effects |
650 | 0 | 4 |
_aMuscle, Skeletal _xdrug effects |
650 | 0 | 4 |
_aNF-kappa B _xgenetics |
650 | 0 | 4 |
_aOxidation-Reduction _xdrug effects |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xgenetics |
650 | 0 | 4 |
_aQuadriceps Muscle _xmetabolism |
650 | 0 | 4 | _aRNA Interference |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xgenetics |
700 | 1 | _aGosker, H R | |
700 | 1 | _aLangen, R C | |
700 | 1 | _aPolkey, M | |
700 | 1 | _aSliwinski, P | |
700 | 1 | _aGaldiz, J | |
700 | 1 | _avan den Borst, B | |
700 | 1 | _aPansters, N A | |
700 | 1 | _aSchols, A M W J | |
773 | 0 |
_tBiochimica et biophysica acta _gvol. 1842 _gno. 2 _gp. 175-85 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbadis.2013.11.001 _zAvailable from publisher's website |
999 |
_c23251838 _d23251838 |